- 現金殖利率: 2.27%、總殖利率: 2.27%、5年平均現金配發率: 87.07%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 8.30 | -2.92 | 6.92 | -1.14 | 0.00 | 0 | 83.37 | 1.83 | 0.00 | 0 | 83.37 | 1.83 |
| 2024 (4) | 8.55 | 66.02 | 7.00 | 66.67 | 0.00 | 0 | 81.87 | 0.39 | 0.00 | 0 | 81.87 | 0.39 |
| 2023 (3) | 5.15 | 44.66 | 4.20 | 31.25 | 0.00 | 0 | 81.55 | -9.27 | 0.00 | 0 | 81.55 | -9.27 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 3.21 | 24.9 | 96.93 | 2.82 | 14.17 | 61.14 | 3.21 | -62.98 | 96.93 |
| 25Q4 (7) | 2.57 | 7.98 | 33.85 | 2.47 | -0.4 | 122.52 | 8.67 | 42.13 | -0.23 |
| 25Q3 (6) | 2.38 | 13.88 | 9.17 | 2.48 | -6.06 | 6.9 | 6.10 | 63.98 | -9.9 |
| 25Q2 (5) | 2.09 | 28.22 | -21.13 | 2.64 | 50.86 | 30.69 | 3.72 | 128.22 | -18.95 |
| 25Q1 (4) | 1.63 | -15.1 | 0.0 | 1.75 | 57.66 | 0.0 | 1.63 | -81.24 | 0.0 |
| 24Q4 (3) | 1.92 | -11.93 | 0.0 | 1.11 | -52.16 | 0.0 | 8.69 | 28.36 | 0.0 |
| 24Q3 (2) | 2.18 | -17.74 | 0.0 | 2.32 | 14.85 | 0.0 | 6.77 | 47.49 | 0.0 |
| 24Q2 (1) | 2.65 | 0.0 | 0.0 | 2.02 | 0.0 | 0.0 | 4.59 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/6 | 8.95 | 10.73 | 45.21 | 45.37 | 25.04 | 25.11 | N/A | - | ||
| 2026/5 | 8.08 | 0.1 | 41.77 | 36.42 | 20.91 | 23.34 | N/A | - | ||
| 2026/4 | 8.07 | 12.35 | 5.25 | 28.33 | 16.04 | 20.63 | N/A | - | ||
| 2026/3 | 7.19 | 33.75 | 12.34 | 20.26 | 20.98 | 20.26 | 0.43 | - | ||
| 2026/2 | 5.37 | -30.24 | 20.32 | 13.07 | 26.31 | 19.08 | 0.46 | - | ||
| 2026/1 | 7.7 | 28.18 | 30.86 | 7.7 | 30.86 | 19.48 | 0.45 | - | ||
| 2025/12 | 6.01 | 4.13 | 14.27 | 75.88 | 12.1 | 18.44 | 0.44 | - | ||
| 2025/11 | 5.77 | -13.44 | 0.34 | 69.87 | 11.91 | 19.63 | 0.42 | - | ||
| 2025/10 | 6.67 | -7.33 | 20.16 | 64.1 | 13.09 | 20.58 | 0.4 | - | ||
| 2025/9 | 7.19 | 7.03 | 21.56 | 57.43 | 12.32 | 21.15 | 0.33 | - | ||
| 2025/8 | 6.72 | -7.17 | 3.62 | 50.24 | 11.11 | 20.12 | 0.34 | - | ||
| 2025/7 | 7.24 | 17.47 | 12.08 | 43.52 | 12.37 | 19.1 | 0.36 | - | ||
| 2025/6 | 6.16 | 8.11 | 2.69 | 36.28 | 12.54 | 19.53 | 0.33 | - | ||
| 2025/5 | 5.7 | -25.68 | -8.23 | 30.12 | 14.66 | 19.77 | 0.33 | - | ||
| 2025/4 | 7.67 | 19.91 | 43.24 | 24.42 | 21.75 | 18.53 | 0.35 | - | ||
| 2025/3 | 6.4 | 43.25 | 13.63 | 16.75 | 13.92 | 16.75 | 0.39 | - | ||
| 2025/2 | 4.47 | -24.13 | 35.74 | 10.35 | 14.11 | 15.61 | 0.42 | - | ||
| 2025/1 | 5.89 | 11.93 | 1.8 | 5.89 | 1.8 | 16.89 | 0.38 | - | ||
| 2024/12 | 5.26 | -8.55 | 14.62 | 67.69 | 36.46 | 16.56 | 0.39 | - | ||
| 2024/11 | 5.75 | 3.65 | 7.92 | 62.43 | 38.68 | 17.21 | 0.37 | - | ||
| 2024/10 | 5.55 | -6.24 | 13.48 | 56.68 | 42.81 | 17.95 | 0.36 | - | ||
| 2024/9 | 5.92 | -8.76 | 21.43 | 51.13 | 46.93 | 18.86 | 0.33 | - | ||
| 2024/8 | 6.49 | 0.39 | 50.08 | 45.22 | 51.08 | 18.95 | 0.33 | 本業及子公司營收成長。 | ||
| 2024/7 | 6.46 | 7.62 | 56.89 | 38.73 | 51.25 | 18.67 | 0.33 | 本業及子公司營收成長。 | ||
| 2024/6 | 6.0 | -3.38 | 59.47 | 32.24 | 50.02 | 17.57 | 0.37 | 本業及子公司營收成長。 | ||
| 2024/5 | 6.21 | 16.0 | 77.54 | 26.27 | 48.18 | 17.2 | 0.38 | 本業及子公司營收成長。 | ||
| 2024/4 | 5.35 | -4.86 | 59.32 | 20.05 | 40.96 | 14.27 | 0.46 | 2023年度成立子公司衡星與併購美國SACO公司，納入合併營收 | ||
| 2024/3 | 5.63 | 71.12 | 29.59 | 14.7 | 35.29 | 14.7 | N/A | - | ||
| 2024/2 | 3.29 | -43.1 | -4.9 | 9.07 | 39.08 | 13.66 | N/A | - | ||
| 2024/1 | 5.78 | 26.03 | 88.77 | 5.78 | 88.77 | 15.7 | N/A | 2023年度成立子公司衡星與併購美國SACO公司，納入合併營收 | ||
| 2023/12 | 4.59 | -13.9 | 32.13 | 49.6 | 14.68 | 14.8 | N/A | - | ||
| 2023/11 | 5.33 | 8.99 | 26.15 | 45.01 | 13.15 | 15.09 | N/A | - | ||
| 2023/10 | 4.89 | 0.31 | 31.76 | 39.69 | 11.61 | 14.08 | N/A | - | ||
| 2023/9 | 4.87 | 12.76 | 26.83 | 34.8 | 9.26 | 13.31 | N/A | - | ||
| 2023/8 | 4.32 | 4.95 | 6.83 | 29.93 | 6.85 | 12.2 | N/A | - | ||
| 2023/7 | 4.12 | 9.39 | 4.99 | 25.61 | 6.86 | 11.38 | N/A | - | ||
| 2023/6 | 3.76 | 7.55 | 2.43 | 21.49 | 7.22 | 10.62 | N/A | - | ||
| 2023/5 | 3.5 | 4.1 | -7.37 | 17.73 | 8.3 | 11.2 | N/A | - | ||
| 2023/4 | 3.36 | -22.62 | 4.19 | 14.23 | 13.0 | 11.16 | N/A | - | ||
| 2023/3 | 4.34 | 25.57 | 42.81 | 10.87 | 16.04 | 10.87 | N/A | - | ||
| 2023/2 | 3.46 | 12.94 | 27.03 | 6.52 | 3.16 | 9.99 | N/A | - | ||
| 2023/1 | 3.06 | -11.77 | -14.9 | 3.06 | -14.9 | 10.76 | N/A | - | ||
| 2022/12 | 3.47 | -17.8 | -8.67 | 43.25 | 11.57 | 11.4 | N/A | - | ||
| 2022/11 | 4.22 | 13.84 | 9.37 | 39.78 | 13.77 | 11.77 | N/A | - | ||
| 2022/10 | 3.71 | -3.43 | 32.27 | 35.56 | 14.32 | 11.6 | N/A | - | ||
| 2022/9 | 3.84 | -5.01 | 6.23 | 31.85 | 12.54 | 11.81 | N/A | - | ||
| 2022/8 | 4.04 | 3.14 | 16.61 | 28.01 | 13.46 | 11.64 | N/A | - | ||
| 2022/7 | 3.92 | 6.72 | 16.94 | 23.96 | 12.95 | 11.37 | N/A | - | ||
| 2022/6 | 3.67 | -2.74 | 7.88 | 20.04 | 12.2 | 10.68 | N/A | - | ||
| 2022/5 | 3.78 | 17.1 | 34.54 | 16.37 | 13.22 | 10.04 | N/A | - | ||
| 2022/4 | 3.23 | 6.05 | -0.96 | 12.59 | 8.08 | 8.99 | N/A | - | ||
| 2022/3 | 3.04 | 11.7 | 1.96 | 9.36 | 11.6 | 9.36 | N/A | - | ||
| 2022/2 | 2.72 | -24.34 | 20.89 | 6.32 | 16.91 | 10.12 | N/A | - | ||
| 2022/1 | 3.6 | -5.31 | 14.08 | 3.6 | 14.08 | 11.26 | N/A | - | ||
| 2021/12 | 3.8 | -1.56 | 2.29 | 38.76 | 8.24 | 10.47 | N/A | - | ||
| 2021/11 | 3.86 | 37.68 | 2.47 | 34.96 | 8.93 | 10.28 | N/A | - | ||
| 2021/10 | 2.8 | -22.44 | -2.58 | 31.1 | 9.79 | 9.89 | N/A | - | ||
| 2021/9 | 3.62 | 4.26 | 13.23 | 28.3 | 11.19 | 10.44 | N/A | - | ||
| 2021/8 | 3.47 | 3.44 | 8.67 | 24.68 | 10.9 | 0.0 | N/A | - | ||
| 2021/7 | 3.35 | -1.53 | 0.38 | 21.21 | 11.27 | 0.0 | N/A | - |